Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early conversion to low-dose calcineurin inhibitor plus sirolimus after kidney transplantation
ChiCTR1800017277Phase 4Recruiting
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sirolimus in kidney transplant (2 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoint: serum creatinine. Started Jul 2018; status: recruiting.
02
Drugs
sirolimus
03
Conditions
kidney transplant
Beyond the preview
Go deeper on ChiCTR1800017277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017277.